TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/14/23 06:00 | 4/12/23 | ONCT | Oncternal Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leavitt Chase C. | CA | O | GC,Secre | P.m | 7 | 0.2900 | 0 | 25 | 31 | 107 | D | ||||||||||||||
1/31/22 16:00 | 1/27/22 | ONCT | Oncternal Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leavitt Chase C. | CA | O | GC,Secre | P.m | 23 | 1.72 | 0 | 14 | 43 | 45 | D | ||||||||||||||
6/15/21 18:00 | 6/11/21 | ONCT | Oncternal Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leavitt Chase C. | CA | O | GC,Secre | P | 8 | 5.45 | 0 | 2 | New | 2 | D | ||||||||||||||
8/15/19 08:42 | 8/13/19 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Leavitt Chase C. | CA | O | GC,Secre | P.d | 5 | 1.02 | 0 | 5 | New | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |